BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22499584)

  • 1. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
    Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
    FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy.
    Geraldes P; Hiraoka-Yamamoto J; Matsumoto M; Clermont A; Leitges M; Marette A; Aiello LP; Kern TS; King GL
    Nat Med; 2009 Nov; 15(11):1298-306. PubMed ID: 19881493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial deletion of PKCδ prevents VEGF inhibition and restores blood flow reperfusion in diabetic ischemic limb.
    Croteau L; Mercier C; Fafard-Couture É; Nadeau A; Robillard S; Breton V; Guay A; Lizotte F; Despatis MA; Geraldes P
    Diab Vasc Dis Res; 2021; 18(2):1479164121999033. PubMed ID: 33722087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes.
    Denhez B; Lizotte F; Guimond MO; Jones N; Takano T; Geraldes P
    J Biol Chem; 2015 Jan; 290(1):350-8. PubMed ID: 25404734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.
    Drapeau N; Lizotte F; Denhez B; Guay A; Kennedy CR; Geraldes P
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1188-98. PubMed ID: 23531619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
    Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes.
    Lizotte F; Denhez B; Guay A; Gévry N; Côté AM; Geraldes P
    Diabetes; 2016 Dec; 65(12):3705-3717. PubMed ID: 27585521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
    Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
    Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKCδ impaired vessel formation and angiogenic factor expression in diabetic ischemic limbs.
    Lizotte F; Paré M; Denhez B; Leitges M; Guay A; Geraldes P
    Diabetes; 2013 Aug; 62(8):2948-57. PubMed ID: 23557702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKCdelta regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K.
    Sataranatarajan K; Lee MJ; Mariappan MM; Feliers D
    Cell Signal; 2008 May; 20(5):969-77. PubMed ID: 18295448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
    Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
    Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease.
    Lizotte F; Rousseau M; Denhez B; Lévesque D; Guay A; Liu H; Moreau J; Higgins S; Sabbagh R; Susztak K; Boisvert FM; Côté AM; Geraldes P
    Kidney Int; 2023 Oct; 104(4):787-802. PubMed ID: 37507049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
    Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
    Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.
    Ku CH; White KE; Dei Cas A; Hayward A; Webster Z; Bilous R; Marshall S; Viberti G; Gnudi L
    Diabetes; 2008 Oct; 57(10):2824-33. PubMed ID: 18647955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.
    Paquin-Veillette J; Lizotte F; Robillard S; Béland R; Breton MA; Guay A; Despatis MA; Geraldes P
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2291-2300. PubMed ID: 29074590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes.
    Kang SW; Natarajan R; Shahed A; Nast CC; LaPage J; Mundel P; Kashtan C; Adler SG
    J Am Soc Nephrol; 2003 Dec; 14(12):3178-87. PubMed ID: 14638916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel podocyte protein, R3h domain containing-like, inhibits TGF-β-induced p38 MAPK and regulates the structure of podocytes and glomerular basement membrane.
    Ishikawa T; Takemoto M; Akimoto Y; Takada-Watanabe A; Yan K; Sakamoto K; Maezawa Y; Suguro M; He L; Tryggvason K; Betsholtz C; Yokote K
    J Mol Med (Berl); 2021 Jun; 99(6):859-876. PubMed ID: 33620517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. eNOS deficiency predisposes podocytes to injury in diabetes.
    Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
    J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.